Melanoma brain metastatis. Animal models, detection and therapy interventions
Has parts
Paper I: Daphu I, Sundstrøm T, Horn S, Huszthy PC, Niclou SP, Sakariassen PO, Immervoll H, Miletic H, Bjerkvig R, Thorsen F. In vivo animal models for studying brain metastasis: value and limitations. Clinical & Experimental Metastasis 2013 Jun;30(5): 695-710. The article is not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1007/s10585-013-9566-9Paper II: Wang J, Daphu I, Pedersen PH, Miletic H, Hovland R, Mørk S, Bjerkvig R, Tiron C, McCormack E, Micklem D, Lorens JB, Immervoll H, Thorsen F. A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients. Neuropathology and Applied Neurobiology 2011 Feb;37(2):189–205. The article is not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1111/j.1365-2990.2010.01119.x
Paper III: Sundstrøm T, Daphu I, Wendelbo I, Hodneland E, Lundervold A, Immervoll H, Skaftnesmo KO, Babic M, Jendelova P, Sykova E, Johansen ML, Bjerkvig R, Thorsen F. Automated Tracking of Nanoparticle-labeled Melanoma Cells Improves the Predictive Power of a Brain Metastasis Model. Cancer Research 2013 Apr;73(8): 2445-56. The article is not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1158/0008-5472.can-12-3514
Paper IV: Daphu I, Horn S, Stieber D, Varughese J, Skaftnesmo KO, Bjerkvig R, Thorsen F. Inhibition of human melanoma brain metastatic growth in vitro by targeting the MAPK and PI3K signaling pathways. The article is not available in BORA.